Skip to main content
. Author manuscript; available in PMC: 2016 Aug 16.
Published in final edited form as: Leukemia. 2015 Jul 13;30(1):173–181. doi: 10.1038/leu.2015.180

Fig. 6.

Fig. 6

QL-X-138 demonstrates anti-proliferation activity against CLL and AML primary patient cells.

All primary cells were cultured and treated for QL-X-138 for 72h before subject to Cell Titer-Glo analysis.